Trial of antiretroviral for HIV prevention on hold.
Khabir
K
Ahmad
D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002160:Cambodia; D018849:Controlled Clinical Trials as Topic / Q000941:ethics* / Q000592:standards; D004311:Double-Blind Method; D028744:Ethics Committees, Research; D032984:Ethics, Research; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007348:Insurance, Health; D007391:International Cooperation; D009316:National Institutes of Health (U.S.); D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D012107:Research Design; D011477:Sex Work; D000068698:Tenofovir; D014481:United States; D014931:Women, Working
D019380:Anti-HIV Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D000068698:Tenofovir; D000225:Adenine